A label-free fluorescence DNA probe based on ligation reaction with quadruplex formation for highly sensitive and selective detection of nicotinamide adenine dinucleotide

2012 ◽  
Vol 48 (37) ◽  
pp. 4468 ◽  
Author(s):  
Jingjin Zhao ◽  
Liangliang Zhang ◽  
Jianhui Jiang ◽  
Guoli Shen ◽  
Ruqin Yu
RSC Advances ◽  
2016 ◽  
Vol 6 (94) ◽  
pp. 91077-91082 ◽  
Author(s):  
Jia Ge ◽  
Zhen-Zhen Dong ◽  
Lin Zhang ◽  
Qi-Yong Cai ◽  
Dong-Mei Bai ◽  
...  

A novel label-free biosensor for high sensing of NAD+ based on dsDNA-templated CuNPs and DNA ligation reaction.


RSC Advances ◽  
2014 ◽  
Vol 4 (51) ◽  
pp. 27091-27097 ◽  
Author(s):  
Qingwang Xue ◽  
Yanqin Lv ◽  
Yuanfu Zhang ◽  
Shuling Xu ◽  
Qiaoli Yue ◽  
...  

A novel label-free amplified fluorescent sensing scheme based on target-responsive dumbbell probe-mediated rolling circle amplification (D-RCA) has been developed for sensitive and selective detection of mercuric ions.


2018 ◽  
Vol 6 (48) ◽  
pp. 8214-8220 ◽  
Author(s):  
Quan Li ◽  
Kaite Peng ◽  
Yanzhen Lu ◽  
Aoxin Li ◽  
Fenfang Che ◽  
...  

Label-free fluorescent ionic liquid-functionalized silicon nanoparticles with tunable amphiphilicity for highly sensitive and selective detection of Hg2+ were synthesized.


The Analyst ◽  
2016 ◽  
Vol 141 (5) ◽  
pp. 1822-1829 ◽  
Author(s):  
Jie Hu ◽  
Qianfen Zhuang ◽  
Yong Wang ◽  
Yongnian Ni

The synergistically enhanced catalytic effect of a Fe2+/molybdenum disulfide (MoS2) nanosheet was exploited to construct a nanozyme biosensor for Fe2+.


2012 ◽  
Vol 4 (5) ◽  
pp. 1310 ◽  
Author(s):  
Yamin Luo ◽  
Peng Wu ◽  
Jing Hu ◽  
Shaopan He ◽  
Xiandeng Hou ◽  
...  

Biosensors ◽  
2021 ◽  
Vol 11 (10) ◽  
pp. 402
Author(s):  
Samuel Husin Surya Mandala ◽  
Tai-Jan Liu ◽  
Chiung-Mei Chen ◽  
Kuo-Kang Liu ◽  
Mochamad Januar ◽  
...  

Parkinson’s disease (PD) is an acute and progressive neurodegenerative disorder, and diagnosis of the disease at its earliest stage is of paramount importance to improve the life expectancy of patients. α-Synuclein (α-syn) is a potential biomarker for the early diagnosis of PD, and there is a great need to develop a biosensing platform that precisely detects α-syn in human body fluids. Herein, we developed a surface plasmon resonance (SPR) biosensor based on the label-free iron oxide nanoparticles (Fe3O4 NPs) and paired antibody for the highly sensitive and selective detection of α-syn in serum samples. The sensitivity of the SPR platform is enhanced significantly by directly depositing Fe3O4 NPs on the Au surface at a high density to increase the decay length of the evanescent field on the Au film. Moreover, the utilization of rabbit-type monoclonal antibody (α-syn-RmAb) immobilized on Au films allows the SPR platform to have a high affinity-selectivity binding performance compared to mouse-type monoclonal antibodies as a common bioreceptor for capturing α-syn molecules. As a result, the current platform has a detection limit of 5.6 fg/mL, which is 20,000-fold lower than that of commercial ELISA. The improved sensor chip can also be easily regenerated to repeat the α-syn measurement with the same sensitivity. Furthermore, the SPR sensor was applied to the direct analysis of α-syn in serum samples. By using a format of paired α-syn-RmAb, the SPR sensor provides a recovery rate in the range from 94.5% to 104.3% to detect the α-syn in diluted serum samples precisely. This work demonstrates a highly sensitive and selective quantification approach to detect α-syn in human biofluids and paves the way for the future development in the early diagnosis of PD.


Sign in / Sign up

Export Citation Format

Share Document